Adhesion molecules as diagnostic tools in tumor pathology

International Journal of Surgical Pathology

Volumn 8, Issue 3, 2000, Pages 191-200

  Ohene Abuakwa, Y ^a   Pignatelli, M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Cadherin; Cancer; CD44; Immunoglobulins; Integrins; Prognosis

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CELL ADHESION MOLECULE; CELL MEMBRANE MARKER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLYCOPROTEIN; HERMES ANTIGEN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; NERVE CELL ADHESION MOLECULE; PADGEM PROTEIN; SELECTIN; UVOMORULIN; VASCULAR CELL ADHESION MOLECULE 1;

CANCER GRADING; CANCER STAGING; CELL INTERACTION; DIAGNOSTIC VALUE; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUMOR;

EID: 0033797355     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/106689690000800306     Document Type: Review

References (100)

1. Cell adhesion molecules: Implications for molecular histology
2. Role of integrins and other cell adhesion molecules in tumor progression and metastasis
3. E-cadherin/catenin: More than a 'sticky' molecular complex
4. The cadherin cell-cell adhesion molecules controlling animal morphogenesis
5. Contact and adhesive specificity in the association, migration, and targeting of cells and axons
6. The immunoglobulin superfamily domain for cell surface recognition
7. The selectins and their ligands
8. CD44 and its interaction with the cellular matrix
9. Morphoregulatory activities of E-cadherin and beta-1 integrin in colorectal tumor cell lines
10. Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer
11. Integrin cell adhesion molecules in colorectal cancer
12. Integrin distribution in malignant melanoma: Association of the β3 subunit with tumor progression
13. Adhesion molecules: Novel molecular tools in tumor pathology
14. Integrins in tumor development and spread
15. Differences in the biosynthesis and differentiation of the fibronectin receptor in normal and transformed cultured human cells
16. Low expression of collagen receptors in moderate and poorly differentiated colorectal adenocarcinomas
17. Low expression of β1, α2, and α3 subunits of VLA integrins in malignant mammary tumors
18. Monoclonal antibody to human carcinoma-associated protein complex: Quantitation in normal and tumor tissue
19. Analysis of the tumor-associated antigen TSP-180: Identity with α6β4 in the integrin superfamily
20. Colorectal cancer and the integrin family of cell adhesion receptors: Current status and future directions
21. Expression of the α9β1 integrin in human colonic epithelial cells: Resurgence of the foetal phenotype in a subset of colonic cancers and adenocarcinoma cell lines
22. Comparison of integrin, cadherin, and catenin expression in squamous cell carcinoma of the oral cavity
23. Characterization of integrin receptor in normal and neoplastic brain
24. Invasion and metastasis
25. Elevated levels of the α5β1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells
26. Integrins and cancer
27. In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells
28. Basal cell carcinoma display extensive abnormalities in the hemidesmosome anchoring fibril complex
29. Loss of co-localization of α6β4 integrin VII in bladder cancer
30. Transforming growth factor alpha can act as morphogen and/or mitogen in colorectal carcinoma cell line
31. The juxtamembrane region of the cadherin cytoplasmic tail support lateral clustering, adhesive strengthening, and interaction with p120(ctn)
32. The epidermal stem cell compartment: Variation in expression levels of E-cadherin and catenin within the basal layer of human epidermis
33. Solution structure of the epithelial cadherin domain responsible for selective cell adhesion
34. Expression of N-cadherin adhesion molecules associated with early morphogenic events in chick development
35. N-cadherin gene maps to human chromosome 18 and is not linked to the E-cadherin gene
36. Expression of P-cadherin identifies prostate-specific-antigen-negative cells in epithelial tissues of male sexual accessory organs and in prostatic carcinomas
37. Cell adhesion molecules as tumor suppressors
38. The E-cadherin/catenin complex in invasion and metastasis
39. The differential expression of N-cadherin and E-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas
40. The differential expression of N-cadherin and E-cadherin distinguishes plueral mesothelioma from lung adenocarcinoma
41. E-cadherin/catenin complex in benign and malignant melanocytic lesions
42. Expression of E-cadherin/catenin complex correlates with macroscopic appearance of early gastric cancer
43. E-cadherin expression in squamous cell carcinomas of the head and neck: Inverse correlation with tumor dedifferentiation and lymph node metastasis
44. Decreased E-cadherin expression correlates with lymph node metastasis, high-grade and advanced stage in pancreatic cancer
45. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors
46. Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma
47. Expression of E-cadherin, α-catenin and β-catenin in normal ovarian surface epithelial and epithelial ovarian cancer
48. Mechanism of inactivation of E-cadherin in breast cancer cell lines
49. Catenins as mediators of the cytoplasmic functions of cadherins
50. Identification of new catenin: The tyrosine kinase substrate pl20cas associates with E-cadherin complexes
51. A truncated β-catenin disrupts the interaction between E-cadherin and α-catenin: A cause of loss of intercellular adhesiveness in human cancer cell lines
52. Expression of E-cadherin-associated molecules (α-, β- and γ-catenins and p120) in colorectal polyps
53. Beta-catenin expression in human cancers
54. Abnormal immunoreactivity of E-cadherin-catenin complex in gastric carcinoma: Relationship with patients survival
55. Lessons from hereditary colorectal cancer
56. Functional mutation of beta-catenin with transcriptional factor LEF-1
57. Somatic mutation of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
58. P120, a p120-related protein (p100) and the cadherin/catenin complexes
59. The effect of tyrosine-specific protein phosphorylation on the assembly of adherens-type junction
60. Identification of a new immunoglobulin superfamily protein expression in blood vessels with a heparin-binding consensus sequence
61. Expression of transduced carcinoembryonic antigen gene in human rhabdomyosarcoma inhibits metastasis
62. Carcinoembryonic antigen functions as an accessory adhesion molecule mediating colon epithelial cell-collagen interactions
63. Transcription of carcinoembryonic antigen in normal colon and colon carcinoma: In situ hybridization study and the implication for a new in vivo functional model
64. Differential expression of CD45/intercellular adhesion molecule 1 in myeloid leukemias and lymphoproliferative disorders
65. Expression of major histocompatibility class I and class II antigens and intercellular adhesion molecules 1 on operable non small cell lung carcinomas: Frequency and prognostic significance
66. Levels of circulating intercellular adhesion molecule 1 in patients with metastatic cancer of the prostate and benign prostate hyperplasia
67. An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma
68. De novo expression of intercellular-adhesion molecule in melanoma correlates with increased risk of metastasis
69. Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions
70. Clinical significance of alpha(v)beta3 intergrin and intercellular adhesion molecule 1 expression in cutaneous malignant melanoma lesions
71. Circulating soluble adhesion molecules levels in children with acute lymphoblastic leukemia
72. Quantitative detection of soluble adhesion molecules in sera of melanoma patients correlates with clinical stage
73. Elevated serum levels of soluble ICAM-1 in non-Hodgkin's lymphoma correlates with tumor burden, clinical activity, and other prognostic markers
74. Serum concentration of intercellular adhesion molecules 1 in patients with hepatocellular carcinoma is a marker of the disease progression and prognosis
75. Soluble vascular cell adhesion molecule-1 (sVCAM) is an independent prognostic marker in Hodgkins's disease
76. Identification of chromosome 18q gene that is altered in colorectal cancers
77. Nonrandom chromosome losses in stepwise neoplastic transformation in vitro of human uroepithelial cells
78. Frequent loss of expression of potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma
79. Immunohistochemical analysis of neural cell adhesion molecules
80. Sialyldomeric Lewis-X antigen expressed on mucin-like glycoprotein in colorectal cancer metastases
81. Tumor cell adhesion to endothelial cells: Endothelial leukocyte adhesion molecule-1 as an inducible adhesive receptor specific for colon carcinoma cells
82. Circulating intercellular adhesion molecules-1 and E-selectin levels in gastric cancer
83. Further characterization of the interaction between L-selectin and its endothelial ligands
84. CD44: A multitude of isoforms with diverse functions
85. CD44 is the principal cell surface receptor for hyaluronate
86. Significance of CD44 gene products for cancer diagnosis and disease evaluation
87. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family
88. The hematopoietic and epithelial forms of CD44 are distinct polypeptydes with different adhesion potentials for hyaluronate bearing cells
89. Analysis of deranged CD44 gene expression in breast, bladder, and colon cancer by correlated studies on mRNA and protein isoform
90. Abnormal expression of human CD44 gene in early colorectal malignancy with specific reference to variant exon 9 (9v)
91. Current status of CD44 variant isoforms as cancer diagnostic markers
92. Expression of CD44 variant protein in human colorectal cancer is related to tumor progression
93. Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma
94. Glycoprotein CD44 expression and its association with survival in breast cancer
95. Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H
96. CD44 splice variant confer metastatic behavior in rats: Homologous sequences are expressed in human tumor cell lines
97. Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas
98. Isolation and characterization of human melanoma cell variants expression high and low levels of CD44
99. A human homologue of the rat metastasis-associated variant in CD44 is expressed in colorectal carcinomas and adenomatous polyps